SU1016314A1 - Process for producing polyester urethanes - Google Patents

Process for producing polyester urethanes Download PDF

Info

Publication number
SU1016314A1
SU1016314A1 SU792854648A SU2854648A SU1016314A1 SU 1016314 A1 SU1016314 A1 SU 1016314A1 SU 792854648 A SU792854648 A SU 792854648A SU 2854648 A SU2854648 A SU 2854648A SU 1016314 A1 SU1016314 A1 SU 1016314A1
Authority
SU
USSR - Soviet Union
Prior art keywords
hydroxyl
melt
oligomer
diol
producing polyester
Prior art date
Application number
SU792854648A
Other languages
Russian (ru)
Inventor
Малхаз Михайлович Заалишвили
Рамаз Давидович Кацарава
Тамара Михайловна Картвелишвили
Original Assignee
Институт Физиологии Им.И.С.Бериташвили
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Институт Физиологии Им.И.С.Бериташвили filed Critical Институт Физиологии Им.И.С.Бериташвили
Priority to SU792854648A priority Critical patent/SU1016314A1/en
Application granted granted Critical
Publication of SU1016314A1 publication Critical patent/SU1016314A1/en

Links

Landscapes

  • Polyurethanes Or Polyureas (AREA)

Abstract

СПОСОБ ПОЛУЧЕНИЯ ПОЛИЭФИРУРЕТАНрВ путем взаимодействи  в . (расплаве сложного гидроксилсодержащего блигоэфира с гексаметилендиизоцианатом в присутствии диола, от- i личающийс  тем, что, с целью придани  конечному продукту биодеградируемых свойств, в качестве сложного гидроксилсодержащего олигоэфира используют соединение общей формулы pf-f 0-сн-со ) со-сн-О ti н, где с 0-20; Е 0-20 (причемЛ 0, t О, , 1. 0); R-Mi CHjилиК р-Н, или R R-CH5V. CHv § -№)2r{ l«2i3 , СИ, Ч ca2)(CH2-o-iMETHOD OF OBTAINING POLYESTERURATANANV through interaction c. (a melt of a hydroxyl-containing glycosyl ester with hexamethylene diisocyanate in the presence of a diol, characterized in that, in order to impart biodegradable properties to the final product, a hydroxyl-containing oligoester is used as a hydroxyl-containing oligoester with a compound of the general formula pf-f 0-ch-co) co-ch-O ti n, where c 0-20; E 0-20 (where L 0, t О,, 1. 0); R-Mi CHjiliK rn, or R R-CH5V. CHv § -№) 2r {l «2i3, SI, H ca2) (CH2-o-i

Description

Изобретение относитс  к синтезу полйэфируретанов, которые могут быть использованы в медицине, например, ; в качестве саморассасьшанмдихс  хирур гических материалов. Известен способ получени  полиэфи уретанов путем взаимодействи  гидроксцлсодержащих олигомеров сложноэфирного- , типа с диизоцианатом в присутствии диола l3. Недостатком известного рпособа получени  полйэфируретанов йвл етс  их непригодность дл  использовани  в медицине в качестве биодеградируемых материалов Наиболее близкий по технической сущности к предлагаемому  вл етс  способ получеин  полйэфируретанов путем взаимодействи  в расплаве слож ного гидроксилсодержащего олигоэФира с гексаметилендиизоцианатом в при- , сутствии диола. В качестве сложного гидроксилсоЬёржащего олигоэФира используют продукт конденсации дикарбоновой кислот и диола, например адипиновой кислоты и этиленгликол  в расплаве С2. Недостатком, полученных известным способом,.полйэфируретанов  вл етс  отсутствие в нх макромолекулах св зей , способных подвергатьс  ферментативной биодеградации. Целью изобретени   вл етс  придание биодеградируемых свойств конечному продукту. Указанна  цель достигаетс  тем, что согласно способу при получении полйэфируретанов путем взаимодействи в расплаве сложного гидроксилсодер ащего олигоэФира используют соедиени  формулы RК II Jlf (Jfl СО-(Н- О -)- Н, де Ч 0-20 0-20 (причем 1с О, С О, ) е О, 1 О R--H R--CHj или R-R-H , или Р Р--СНэ, , .СНз R- - 1 5Н21г rl iHjts , (jHj iCH2)2-iH-,-(SH2)f-0-( и процесс провод т ступенчато: при 90-120с в течение 0,5-1 ч, при 160190°С в течение 4-5 ч. Блоксополимерную структуру полученных полимеров подтверждают изучением их растворимости в органических растворител х и сравнением с растворимостью соответствующих гомополимеров , а также изучением их ИК- и ЯМР-спектров. синтезированные полиэФируретаны облгщают пленко- и волокнообразующими свойствами- Они раствор ютс  во многих органических раст ворител х, образу  высококонцентрированные растворы, из этих раствором методом полива на стекл нные подложки были получены эластичные пленки, имеющие прочность на разрыв 300400 кг/см2 и разрывное удлинение 100200% . Строение и характеристики испольгюванных полиэфирных смол привод тс . в табл.1. Т а б л и ц а 1This invention relates to the synthesis of polyether urethanes that can be used in medicine, for example; as a samorasshansmidkhs surgical materials. A known method of producing polyether urethanes by reacting hydroxyl-containing oligomers of an ester- type, with a diisocyanate in the presence of a diol l3. A disadvantage of the known method of producing polyether urethanes is their unsuitability for use in medicine as biodegradable materials. The most similar in technical essence to the proposed method is the method of obtaining polyether urethanes by melting complex hydroxyl-containing oligophira with the hexamethyleni-iso-isocyanate iannidar i'm i'm i'm io4 i4i4i4i4i-4y; As a complex hydroxyl-bearing oligo-efir, a condensation product of dicarboxylic acids and a diol, for example, adipic acid and ethylene glycol in the C2 melt, is used. A disadvantage obtained in a known manner, polyetheruretans, is the absence of bonds in their macromolecules capable of undergoing enzymatic biodegradation. The aim of the invention is to impart biodegradable properties to the final product. This goal is achieved by the fact that, according to the method for obtaining polyetheruretans, by using a compound of the formula RK II Jlf (Jfl CO- (H - O -) - H, de H 0-20 0-20 (1C O , С О,) е О, 1 О R - H R - CHj or RRH, or Р Р - СНэ,, .СНз R- - 1 5Н21г rl iHjts, (jHj iCH2) 2-iH -, - ( SH2) f-0- (and the process is carried out in steps: at 90-120 s for 0.5-1 h, at 160190 ° C for 4-5 h. The block-polymer structure of the obtained polymers is confirmed by studying their solubility in organic solvents and by comparison with solubility with the corresponding homopolymers, as well as the study of their IR and NMR spectra. The synthesized polyfiruretans exhibit film- and fiber-forming properties. They dissolve in many organic diluents, forming highly concentrated solutions, and elastic films were obtained from these solutions by pouring onto glass substrates. having a tensile strength of 300,400 kg / cm2 and a tensile elongation of 100,200%. The structure and characteristics of used polyester resins are given. in table.1. Table 1

Пример 1.В трехгорлую , снабженную мешалкой, вводом и выводом дл  аргона помещают 0,005 моль олигомера СЭ-1-0 (табл.1) и колбу нагревают до 120-125°С. К образовавшемус  расплаву добавл ют половину (0,05 моль) гексаметилендиизоцианата (суммарное количество гексаметилендиизоцианата 0,1 моль). Расплав перемешивают в течение 30 мин, после .чеГО температуру снижают до 90-10Ь°С и ввод т Qf095 моль удлинител  (диола )S 1,3-пропандиола. Смесь вновь .нагребают до и перемешивают еще 30 мий к затем осторожно, по пор ) ди м ввод т оставше ес  количество (0,05 моль дииэоцианата). Реакционна масра быстро загустевает и не переме шиваетс . Температуру медленно повышают до так, чтобы реакционна  смесь легко пе ремешивалась и выдержи Ьают при данной температуре в течени 4 ч Расплав выливают на чашку Петри и охлаждают. Приведенна  в зкость 0,64 д-л/г в м-крезоле, t 2УС, С в 0,5 г/дл. . Пример 2. В трехгорлую Колбу , снабженную мешалкой, вводоми выводом дл  аргона помещают 0,0в5 мо олигомёра СЭ-06-04, колбу нагревают до 9Q°C и к образоваввюмус  расплаву добавл ют половину 0,05 моль гексаметилендиизоцианата . Реакционную смеЪь нагревают до в течение 30 мин затем охлаждают до 90°С и ввод т 0, моль пропандиола, вновь нагревают ДО 120°С в течение 30 миН охлаждают до 90°е и осторожно ввод т оставшеес  количество диизоцианата. Смесь медленно нагревают до 1бО°С, причем теютературу повышают так, чтобы в колбе был хорошо перемешиваеквдй расплав. Реакционную смесь: вы держивают при в течение 5 ч,, после чеговыливают на чашку Петри н охлаждают. Чпр 0,58 дл/г в смеси тетрахлорзтан: фенол (3:1), t° 25с, С 0,5 г/дл. Пример 3. Синтез полимера осуществл ют в соответствии с методикой , приведенной в. примере 2, с той лишь разницей, что вместо олиго-, мера СЭ-Об-04 (табл.) используют олигомер СЭ-05-05 (табл.1), а вкачестве удлинител  цепи вместо.1,3пропандиола используют зтиленгликольц 0,52 дл/г в смеси тетрахлорт зтан: енол (3:1), t 25«с, С 0,5 г/дл. Пример 4. Синтез полимера осуществл ют в соответствии с методикой приведенной в примере 2, с той разницей, что вместо оп гомера СЭ-06-04; берут олигомер СЭ-05-05, . 0,5d дл/г в смеси тетрёиелорэтана с фенолом 3:l,t° 25°С, С 0,5 г/дл,, П р и м е р 5. Синтез полимера осуществл ют в соответствии с методикой , приведенной впримере 2 с -той разницей, что вместо олигомёра СЭ-06-04 берут олигомер СЭ-04-05, «Injp 0,4 дл/г в смеси тетрахлорэтана С фенолом 3:1, t , С 0,5 г/дл. Пример 6. СийЧгез полимера осуществл ют в соответствии с методикой , приведенной в примере 2, с той разницей, что вместо олигомёра СЭ-06-04 берут олигомер СЭ-0-1 , - 0,48 дл/г в смеси твтргослорэтана с фенолом (3:1), t® 25°С, С 0,5 г/дл. Пример 7. Синтез пЬлимера осу1цествл 1от в соответствии с методикой , приведенной в примере 1, с той разницей, что вместо олигомёра СЭ-1-0 беруt олигомер СП-1-0 (табл.1) H«p 0,60 дл/г в м-крезоле, , С 0,5 г/дл. Услови  синтеза и основные характеристики полученнш полиэфируретанов приведены в табл.2.Example 1. In a three-necked, equipped with a stirrer, the input and output for argon is placed 0.005 mol of oligomer SE-1-0 (table 1) and the flask is heated to 120-125 ° C. To the resulting melt, half (0.05 mol) of hexamethylene diisocyanate is added (the total amount of hexamethylene diisocyanate is 0.1 mol). The melt is stirred for 30 minutes, after which the temperature is lowered to 90-10 ° C and Qf095 mol of the extender (diol) S 1,3-propanediol is introduced. The mixture is refilled again and stirred for another 30 missions, then carefully, at times, the remaining amount (0.05 mol of di-isocyanate) is added. The reaction mixture thickens rapidly and is not stirred. The temperature is slowly raised until the reaction mixture is easily stirred and kept at this temperature for 4 hours. The melt is poured onto a Petri dish and cooled. The reduced viscosity is 0.64 dl / g in m-cresol, t 2US, С at 0.5 g / dL. . Example 2. In a three-necked flask equipped with a stirrer, an inlet for argon was placed with 0.0–5 mo of SE-06-04 oligomer, the flask was heated to 9Q ° C, and half of 0.05 mole of hexamethylene diisocyanate was added to the melt. The reaction mixture is heated to 30 minutes, then cooled to 90 ° C and 0 mol of propane diol is introduced, heated to 120 ° C again for 30 min to 90 ° C and the remaining amount of diisocyanate is carefully added. The mixture is slowly heated to 1 ° C, and the temperature is increased so that the flask has a well mixed melt. The reaction mixture: you are kept at for 5 h after it is poured onto a Petri dish and cooled. Chpr 0,58 dl / g in a mixture of tetrachlorotane: phenol (3: 1), t ° 25s, With 0.5 g / dl. Example 3. Synthesis of the polymer was carried out in accordance with the procedure given in c. Example 2, with the only difference that instead of oligo-, measure СЭ-Об-04 (table), use oligomer СЭ-05-05 (table 1), and as a chain extender instead of 1.3 propandiol use ethylene glycol 0.52 dl / g in a mixture of tetrachloride ztan: enol (3: 1), t 25 "s, C 0.5 g / dl. Example 4. Synthesis of the polymer was carried out in accordance with the procedure described in example 2, with the difference that instead of the opomer SE-06-04; take oligomer SE-05-05,. 0.5d dl / g in a mixture of tetroyelorethan with phenol 3: l, t ° 25 ° C, 0.5 g / dL, Example 5 Polymer synthesis is carried out in accordance with the procedure given in Example 2 with the difference that instead of an oligomer of SE-06-04 an oligomer of SE-04-05 is taken, “Injp 0.4 dl / g in a mixture of tetrachloroethane With phenol 3: 1, t, C 0.5 g / dl. EXAMPLE 6 Polymer Synthesis was carried out in accordance with the procedure described in Example 2, with the difference that instead of the SE-06-04 oligomer, the SE-0-1 oligomer was taken to be 0.48 dl / g in a mixture of tvtssloroethane and phenol ( 3: 1), t® 25 ° С, С 0.5 g / dl. Example 7. Synthesis of catalyst size is 1 according to the procedure described in example 1, with the difference that instead of oligomer СЭ-1-0 take SP-1-0 oligomer (Table 1) H «p 0.60 dl / g in m-cresol, C 0.5 g / dl. The synthesis conditions and the main characteristics of the polyether urethanes obtained are given in Table 2.

Таким образом, п менение предлагаемого способа получени  полиэфируретанов , содержащих в цеп х макромолекул олигоэфирные блоки на осиове ici-оксикислот Обеспечивает следук цие преимущества: использование в качестве исходных смол олигоэфиров на основе Ыгоксикислот позвол ет получать полиэфируретаны содержгицие в цеп х макро{молекул о6 дфнрные св зи способны под--, вергатьс  ферментативной биодегргц1ацииThus, the proposed method of producing polyether urethanes containing oligoester blocks on the chain of ici-hydroxy acids in the chains of macromolecules provides the following advantages: using polyhydric esters based on polyhydroxy esters as the starting resin allows zi capable of underwater fermentation biodegradation

полученные полизфируретаны полезны дл  11спользованн  в медицине в качестве саморассасывающихс  материалов , поскольку содержат в цеп х макромолекул биодеградируемые cL-зфирные св зи;The resulting polyesterutanes are useful in medicine as self-absorbing materials, since they contain biodegradable cl-spherical bonds in the chains of macromolecules;

растворимость полученных полиэфируретанов в органических растворител х , что облегчает их переработку в издели -пленки, пористые материалы и т.д.the solubility of the obtained polyether urethane in organic solvents, which facilitates their processing into articles - films, porous materials, etc.

Claims (1)

СПОСОБ ПОЛУЧЕНИЯ ПОЛИЭФИРУРЕТАНОВ путем взаимодействия в (расплаве сложного гидроксилсодержащего олигоэфира с гексаметилендиизо- цианатом в присутствии диола, от- ι личающийся тем, что, с целью придания конечному продукту биодеградируемых свойств, в качестве сложного гидроксилсодержащего олигоэфира используют соединение общей формулы .METHOD FOR PRODUCING POLYETHYRETHRETANES by reacting in a (melt of a complex hydroxyl-containing oligoester with hexamethylene diisocyanate in the presence of a diol), characterized in that, in order to give the final product biodegradable properties, a complex hydroxyl-containing oligoester is used as the complex compound. « В* ^-(0-^-60)^0^0-(-00-^-0¼^ где к = е = (причем"B * ^ - (0 - ^ - 60) ^ 0 ^ 0 - (- 00 - ^ - 0¼ ^ where k = e = (and R-WjR-wj 0-20;0-20; 0-20 х= о, его, е = о, к* о);0-20 x = o, him, e = o, k * o); или R=R’-H , или a”- -(«ЧЪ 6Й3 4^2)2-(^1-,-^2-0-^2)2, и процесс проводят ступенчато: 90-120°С в течение 0,5-1 чт при 160 190°С в течение 4-5 ч.or R = R'-H, or a ”- - (“ ЧЬ 6Й 3 4 ^ 2) 2 - (^ 1 -, - ^ 2-0- ^ 2) 2, and the process is carried out stepwise: 90-120 ° С for 0.5-1 hours at a 160 190 ° C for 4-5 hours.
SU792854648A 1979-12-17 1979-12-17 Process for producing polyester urethanes SU1016314A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SU792854648A SU1016314A1 (en) 1979-12-17 1979-12-17 Process for producing polyester urethanes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SU792854648A SU1016314A1 (en) 1979-12-17 1979-12-17 Process for producing polyester urethanes

Publications (1)

Publication Number Publication Date
SU1016314A1 true SU1016314A1 (en) 1983-05-07

Family

ID=20865692

Family Applications (1)

Application Number Title Priority Date Filing Date
SU792854648A SU1016314A1 (en) 1979-12-17 1979-12-17 Process for producing polyester urethanes

Country Status (1)

Country Link
SU (1) SU1016314A1 (en)

Cited By (84)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0593975A1 (en) * 1992-10-19 1994-04-27 Bayer Ag Use of thermoplastic poly(ester-urethane) as a compostable plastic
US5380813A (en) * 1992-10-16 1995-01-10 Neste Oy Method for producing lactic acid based polyurethane
WO1997040111A1 (en) * 1996-04-18 1997-10-30 Bayer Aktiengesellschaft Compostable waterproof coating
US6372876B1 (en) 1992-07-29 2002-04-16 Basf Aktiengesellschaft Use of polyurethanes which are soluble or dispersible in water as aids in cosmetic and pharmaceutical compositions, and polyurethanes which contain polylactic acid polyols as copolymerized units
US6503538B1 (en) 2000-08-30 2003-01-07 Cornell Research Foundation, Inc. Elastomeric functional biodegradable copolyester amides and copolyester urethanes
US7304122B2 (en) 2001-08-30 2007-12-04 Cornell Research Foundation, Inc. Elastomeric functional biodegradable copolyester amides and copolyester urethanes
US7648727B2 (en) 2004-08-26 2010-01-19 Advanced Cardiovascular Systems, Inc. Methods for manufacturing a coated stent-balloon assembly
US7648725B2 (en) 2002-12-12 2010-01-19 Advanced Cardiovascular Systems, Inc. Clamp mandrel fixture and a method of using the same to minimize coating defects
US7682669B1 (en) 2001-07-30 2010-03-23 Advanced Cardiovascular Systems, Inc. Methods for covalently immobilizing anti-thrombogenic material into a coating on a medical device
US7691401B2 (en) 2000-09-28 2010-04-06 Advanced Cardiovascular Systems, Inc. Poly(butylmethacrylate) and rapamycin coated stent
US7699889B2 (en) 2004-12-27 2010-04-20 Advanced Cardiovascular Systems, Inc. Poly(ester amide) block copolymers
US7713637B2 (en) 2006-03-03 2010-05-11 Advanced Cardiovascular Systems, Inc. Coating containing PEGylated hyaluronic acid and a PEGylated non-hyaluronic acid polymer
US7735449B1 (en) 2005-07-28 2010-06-15 Advanced Cardiovascular Systems, Inc. Stent fixture having rounded support structures and method for use thereof
US7749263B2 (en) 2004-10-29 2010-07-06 Abbott Cardiovascular Systems Inc. Poly(ester amide) filler blends for modulation of coating properties
US7758881B2 (en) 2004-06-30 2010-07-20 Advanced Cardiovascular Systems, Inc. Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders with an implantable medical device
US7766884B2 (en) 2004-08-31 2010-08-03 Advanced Cardiovascular Systems, Inc. Polymers of fluorinated monomers and hydrophilic monomers
US7772359B2 (en) 2003-12-19 2010-08-10 Advanced Cardiovascular Systems, Inc. Biobeneficial polyamide/polyethylene glycol polymers for use with drug eluting stents
US7776926B1 (en) 2002-12-11 2010-08-17 Advanced Cardiovascular Systems, Inc. Biocompatible coating for implantable medical devices
US7775178B2 (en) 2006-05-26 2010-08-17 Advanced Cardiovascular Systems, Inc. Stent coating apparatus and method
US7785512B1 (en) 2003-07-31 2010-08-31 Advanced Cardiovascular Systems, Inc. Method and system of controlled temperature mixing and molding of polymers with active agents for implantable medical devices
US7785647B2 (en) 2005-07-25 2010-08-31 Advanced Cardiovascular Systems, Inc. Methods of providing antioxidants to a drug containing product
US7795467B1 (en) 2005-04-26 2010-09-14 Advanced Cardiovascular Systems, Inc. Bioabsorbable, biobeneficial polyurethanes for use in medical devices
US7794743B2 (en) 2002-06-21 2010-09-14 Advanced Cardiovascular Systems, Inc. Polycationic peptide coatings and methods of making the same
US7803394B2 (en) 2002-06-21 2010-09-28 Advanced Cardiovascular Systems, Inc. Polycationic peptide hydrogel coatings for cardiovascular therapy
US7803406B2 (en) 2002-06-21 2010-09-28 Advanced Cardiovascular Systems, Inc. Polycationic peptide coatings and methods of coating implantable medical devices
US7807211B2 (en) 1999-09-03 2010-10-05 Advanced Cardiovascular Systems, Inc. Thermal treatment of an implantable medical device
US7807210B1 (en) 2000-10-31 2010-10-05 Advanced Cardiovascular Systems, Inc. Hemocompatible polymers on hydrophobic porous polymers
US7820732B2 (en) 2004-04-30 2010-10-26 Advanced Cardiovascular Systems, Inc. Methods for modulating thermal and mechanical properties of coatings on implantable devices
US7823533B2 (en) 2005-06-30 2010-11-02 Advanced Cardiovascular Systems, Inc. Stent fixture and method for reducing coating defects
US7867547B2 (en) 2005-12-19 2011-01-11 Advanced Cardiovascular Systems, Inc. Selectively coating luminal surfaces of stents
US7892592B1 (en) 2004-11-30 2011-02-22 Advanced Cardiovascular Systems, Inc. Coating abluminal surfaces of stents and other implantable medical devices
US7976891B1 (en) 2005-12-16 2011-07-12 Advanced Cardiovascular Systems, Inc. Abluminal stent coating apparatus and method of using focused acoustic energy
US7985440B2 (en) 2001-06-27 2011-07-26 Advanced Cardiovascular Systems, Inc. Method of using a mandrel to coat a stent
US7985441B1 (en) 2006-05-04 2011-07-26 Yiwen Tang Purification of polymers for coating applications
US8003156B2 (en) 2006-05-04 2011-08-23 Advanced Cardiovascular Systems, Inc. Rotatable support elements for stents
US8007775B2 (en) 2004-12-30 2011-08-30 Advanced Cardiovascular Systems, Inc. Polymers containing poly(hydroxyalkanoates) and agents for use with medical articles and methods of fabricating the same
US8017237B2 (en) 2006-06-23 2011-09-13 Abbott Cardiovascular Systems, Inc. Nanoshells on polymers
US8017140B2 (en) 2004-06-29 2011-09-13 Advanced Cardiovascular System, Inc. Drug-delivery stent formulations for restenosis and vulnerable plaque
US8021676B2 (en) 2005-07-08 2011-09-20 Advanced Cardiovascular Systems, Inc. Functionalized chemically inert polymers for coatings
US8029816B2 (en) 2006-06-09 2011-10-04 Abbott Cardiovascular Systems Inc. Medical device coated with a coating containing elastin pentapeptide VGVPG
US8048448B2 (en) 2006-06-15 2011-11-01 Abbott Cardiovascular Systems Inc. Nanoshells for drug delivery
US8048441B2 (en) 2007-06-25 2011-11-01 Abbott Cardiovascular Systems, Inc. Nanobead releasing medical devices
US8052912B2 (en) 2003-12-01 2011-11-08 Advanced Cardiovascular Systems, Inc. Temperature controlled crimping
US8062350B2 (en) 2006-06-14 2011-11-22 Abbott Cardiovascular Systems Inc. RGD peptide attached to bioabsorbable stents
US8067025B2 (en) 2006-02-17 2011-11-29 Advanced Cardiovascular Systems, Inc. Nitric oxide generating medical devices
US8067023B2 (en) 2002-06-21 2011-11-29 Advanced Cardiovascular Systems, Inc. Implantable medical devices incorporating plasma polymerized film layers and charged amino acids
US8109904B1 (en) 2007-06-25 2012-02-07 Abbott Cardiovascular Systems Inc. Drug delivery medical devices
US8110211B2 (en) 2004-09-22 2012-02-07 Advanced Cardiovascular Systems, Inc. Medicated coatings for implantable medical devices including polyacrylates
US8147769B1 (en) 2007-05-16 2012-04-03 Abbott Cardiovascular Systems Inc. Stent and delivery system with reduced chemical degradation
US8173199B2 (en) 2002-03-27 2012-05-08 Advanced Cardiovascular Systems, Inc. 40-O-(2-hydroxy)ethyl-rapamycin coated stent
US8192752B2 (en) 2003-11-21 2012-06-05 Advanced Cardiovascular Systems, Inc. Coatings for implantable devices including biologically erodable polyesters and methods for fabricating the same
US8197879B2 (en) 2003-09-30 2012-06-12 Advanced Cardiovascular Systems, Inc. Method for selectively coating surfaces of a stent
US8293890B2 (en) 2004-04-30 2012-10-23 Advanced Cardiovascular Systems, Inc. Hyaluronic acid based copolymers
US8303651B1 (en) 2001-09-07 2012-11-06 Advanced Cardiovascular Systems, Inc. Polymeric coating for reducing the rate of release of a therapeutic substance from a stent
US8304012B2 (en) 2006-05-04 2012-11-06 Advanced Cardiovascular Systems, Inc. Method for drying a stent
US8357391B2 (en) 2004-07-30 2013-01-22 Advanced Cardiovascular Systems, Inc. Coatings for implantable devices comprising poly (hydroxy-alkanoates) and diacid linkages
US8435550B2 (en) 2002-12-16 2013-05-07 Abbot Cardiovascular Systems Inc. Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders with an implantable medical device
US8506617B1 (en) 2002-06-21 2013-08-13 Advanced Cardiovascular Systems, Inc. Micronized peptide coated stent
US8568764B2 (en) 2006-05-31 2013-10-29 Advanced Cardiovascular Systems, Inc. Methods of forming coating layers for medical devices utilizing flash vaporization
US8586069B2 (en) 2002-12-16 2013-11-19 Abbott Cardiovascular Systems Inc. Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders
US8597673B2 (en) 2006-12-13 2013-12-03 Advanced Cardiovascular Systems, Inc. Coating of fast absorption or dissolution
US8603530B2 (en) 2006-06-14 2013-12-10 Abbott Cardiovascular Systems Inc. Nanoshell therapy
US8603634B2 (en) 2004-10-27 2013-12-10 Abbott Cardiovascular Systems Inc. End-capped poly(ester amide) copolymers
US8609123B2 (en) 2004-11-29 2013-12-17 Advanced Cardiovascular Systems, Inc. Derivatized poly(ester amide) as a biobeneficial coating
US8647655B2 (en) 2002-12-11 2014-02-11 Abbott Cardiovascular Systems Inc. Biocompatible polyacrylate compositions for medical applications
US8652504B2 (en) 2005-09-22 2014-02-18 Medivas, Llc Solid polymer delivery compositions and methods for use thereof
US8673334B2 (en) 2003-05-08 2014-03-18 Abbott Cardiovascular Systems Inc. Stent coatings comprising hydrophilic additives
US8685431B2 (en) 2004-03-16 2014-04-01 Advanced Cardiovascular Systems, Inc. Biologically absorbable coatings for implantable devices based on copolymers having ester bonds and methods for fabricating the same
US8703169B1 (en) 2006-08-15 2014-04-22 Abbott Cardiovascular Systems Inc. Implantable device having a coating comprising carrageenan and a biostable polymer
US8703167B2 (en) 2006-06-05 2014-04-22 Advanced Cardiovascular Systems, Inc. Coatings for implantable medical devices for controlled release of a hydrophilic drug and a hydrophobic drug
US8741378B1 (en) 2001-06-27 2014-06-03 Advanced Cardiovascular Systems, Inc. Methods of coating an implantable device
US8778014B1 (en) 2004-03-31 2014-07-15 Advanced Cardiovascular Systems, Inc. Coatings for preventing balloon damage to polymer coated stents
US8778375B2 (en) 2005-04-29 2014-07-15 Advanced Cardiovascular Systems, Inc. Amorphous poly(D,L-lactide) coating
US9028859B2 (en) 2006-07-07 2015-05-12 Advanced Cardiovascular Systems, Inc. Phase-separated block copolymer coatings for implantable medical devices
US9056155B1 (en) 2007-05-29 2015-06-16 Abbott Cardiovascular Systems Inc. Coatings having an elastic primer layer
US9102830B2 (en) 2005-09-22 2015-08-11 Medivas, Llc Bis-(α-amino)-diol-diester-containing poly (ester amide) and poly (ester urethane) compositions and methods of use
US9114198B2 (en) 2003-11-19 2015-08-25 Advanced Cardiovascular Systems, Inc. Biologically beneficial coatings for implantable devices containing fluorinated polymers and methods for fabricating the same
US9339592B2 (en) 2004-12-22 2016-05-17 Abbott Cardiovascular Systems Inc. Polymers of fluorinated monomers and hydrocarbon monomers
US9375445B2 (en) 2004-06-18 2016-06-28 Abbott Cardiovascular Systems Inc. Heparin prodrugs and drug delivery stents formed therefrom
US9517203B2 (en) 2000-08-30 2016-12-13 Mediv As, Llc Polymer particle delivery compositions and methods of use
US9561351B2 (en) 2006-05-31 2017-02-07 Advanced Cardiovascular Systems, Inc. Drug delivery spiral coil construct
US9561309B2 (en) 2004-05-27 2017-02-07 Advanced Cardiovascular Systems, Inc. Antifouling heparin coatings
US9580558B2 (en) 2004-07-30 2017-02-28 Abbott Cardiovascular Systems Inc. Polymers containing siloxane monomers
US10076591B2 (en) 2010-03-31 2018-09-18 Abbott Cardiovascular Systems Inc. Absorbable coating for implantable device

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
1. Губанов Э.Ф., Тейтельбаум Б.Я., Апухтина Н.П. и Синайский А.Г. Зависимость некоторых свойств полиэфируретановых блрксополимеров от молекул рного веса блоков. Синтез и изико-хими полимеров (полиуретаны) . К., Науковa Думка , 1968, с. 168. 2. Липатова Т.Э., Лоос С.С. и Момбужай М.М. Взаимодействие полиэфируретанов с физиологически активными средами. Высокомолекул рные соединени А 12. 1970, с. 20-51 (прототип) . *

Cited By (111)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6372876B1 (en) 1992-07-29 2002-04-16 Basf Aktiengesellschaft Use of polyurethanes which are soluble or dispersible in water as aids in cosmetic and pharmaceutical compositions, and polyurethanes which contain polylactic acid polyols as copolymerized units
US5380813A (en) * 1992-10-16 1995-01-10 Neste Oy Method for producing lactic acid based polyurethane
EP0593975A1 (en) * 1992-10-19 1994-04-27 Bayer Ag Use of thermoplastic poly(ester-urethane) as a compostable plastic
WO1997040111A1 (en) * 1996-04-18 1997-10-30 Bayer Aktiengesellschaft Compostable waterproof coating
US7807211B2 (en) 1999-09-03 2010-10-05 Advanced Cardiovascular Systems, Inc. Thermal treatment of an implantable medical device
US7408018B2 (en) 2000-08-30 2008-08-05 Cornell Research Foundation, Inc. Elastomeric functional biodegradable copolyester amides and copolyester urethanes
US6503538B1 (en) 2000-08-30 2003-01-07 Cornell Research Foundation, Inc. Elastomeric functional biodegradable copolyester amides and copolyester urethanes
US9517203B2 (en) 2000-08-30 2016-12-13 Mediv As, Llc Polymer particle delivery compositions and methods of use
US7691401B2 (en) 2000-09-28 2010-04-06 Advanced Cardiovascular Systems, Inc. Poly(butylmethacrylate) and rapamycin coated stent
US7807210B1 (en) 2000-10-31 2010-10-05 Advanced Cardiovascular Systems, Inc. Hemocompatible polymers on hydrophobic porous polymers
US10064982B2 (en) 2001-06-27 2018-09-04 Abbott Cardiovascular Systems Inc. PDLLA stent coating
US8741378B1 (en) 2001-06-27 2014-06-03 Advanced Cardiovascular Systems, Inc. Methods of coating an implantable device
US7985440B2 (en) 2001-06-27 2011-07-26 Advanced Cardiovascular Systems, Inc. Method of using a mandrel to coat a stent
US7682669B1 (en) 2001-07-30 2010-03-23 Advanced Cardiovascular Systems, Inc. Methods for covalently immobilizing anti-thrombogenic material into a coating on a medical device
US7304122B2 (en) 2001-08-30 2007-12-04 Cornell Research Foundation, Inc. Elastomeric functional biodegradable copolyester amides and copolyester urethanes
US8303651B1 (en) 2001-09-07 2012-11-06 Advanced Cardiovascular Systems, Inc. Polymeric coating for reducing the rate of release of a therapeutic substance from a stent
US8961588B2 (en) 2002-03-27 2015-02-24 Advanced Cardiovascular Systems, Inc. Method of coating a stent with a release polymer for 40-O-(2-hydroxy)ethyl-rapamycin
US8173199B2 (en) 2002-03-27 2012-05-08 Advanced Cardiovascular Systems, Inc. 40-O-(2-hydroxy)ethyl-rapamycin coated stent
US7794743B2 (en) 2002-06-21 2010-09-14 Advanced Cardiovascular Systems, Inc. Polycationic peptide coatings and methods of making the same
US7803406B2 (en) 2002-06-21 2010-09-28 Advanced Cardiovascular Systems, Inc. Polycationic peptide coatings and methods of coating implantable medical devices
US7901703B2 (en) 2002-06-21 2011-03-08 Advanced Cardiovascular Systems, Inc. Polycationic peptides for cardiovascular therapy
US7875286B2 (en) 2002-06-21 2011-01-25 Advanced Cardiovascular Systems, Inc. Polycationic peptide coatings and methods of coating implantable medical devices
US8506617B1 (en) 2002-06-21 2013-08-13 Advanced Cardiovascular Systems, Inc. Micronized peptide coated stent
US8067023B2 (en) 2002-06-21 2011-11-29 Advanced Cardiovascular Systems, Inc. Implantable medical devices incorporating plasma polymerized film layers and charged amino acids
US9084671B2 (en) 2002-06-21 2015-07-21 Advanced Cardiovascular Systems, Inc. Methods of forming a micronized peptide coated stent
US7803394B2 (en) 2002-06-21 2010-09-28 Advanced Cardiovascular Systems, Inc. Polycationic peptide hydrogel coatings for cardiovascular therapy
US8871883B2 (en) 2002-12-11 2014-10-28 Abbott Cardiovascular Systems Inc. Biocompatible coating for implantable medical devices
US8986726B2 (en) 2002-12-11 2015-03-24 Abbott Cardiovascular Systems Inc. Biocompatible polyacrylate compositions for medical applications
US8871236B2 (en) 2002-12-11 2014-10-28 Abbott Cardiovascular Systems Inc. Biocompatible polyacrylate compositions for medical applications
US7776926B1 (en) 2002-12-11 2010-08-17 Advanced Cardiovascular Systems, Inc. Biocompatible coating for implantable medical devices
US8647655B2 (en) 2002-12-11 2014-02-11 Abbott Cardiovascular Systems Inc. Biocompatible polyacrylate compositions for medical applications
US7648725B2 (en) 2002-12-12 2010-01-19 Advanced Cardiovascular Systems, Inc. Clamp mandrel fixture and a method of using the same to minimize coating defects
US8435550B2 (en) 2002-12-16 2013-05-07 Abbot Cardiovascular Systems Inc. Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders with an implantable medical device
US8586069B2 (en) 2002-12-16 2013-11-19 Abbott Cardiovascular Systems Inc. Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders
US9175162B2 (en) 2003-05-08 2015-11-03 Advanced Cardiovascular Systems, Inc. Methods for forming stent coatings comprising hydrophilic additives
US8673334B2 (en) 2003-05-08 2014-03-18 Abbott Cardiovascular Systems Inc. Stent coatings comprising hydrophilic additives
US7785512B1 (en) 2003-07-31 2010-08-31 Advanced Cardiovascular Systems, Inc. Method and system of controlled temperature mixing and molding of polymers with active agents for implantable medical devices
US8197879B2 (en) 2003-09-30 2012-06-12 Advanced Cardiovascular Systems, Inc. Method for selectively coating surfaces of a stent
US9114198B2 (en) 2003-11-19 2015-08-25 Advanced Cardiovascular Systems, Inc. Biologically beneficial coatings for implantable devices containing fluorinated polymers and methods for fabricating the same
US8192752B2 (en) 2003-11-21 2012-06-05 Advanced Cardiovascular Systems, Inc. Coatings for implantable devices including biologically erodable polyesters and methods for fabricating the same
USRE45744E1 (en) 2003-12-01 2015-10-13 Abbott Cardiovascular Systems Inc. Temperature controlled crimping
US8052912B2 (en) 2003-12-01 2011-11-08 Advanced Cardiovascular Systems, Inc. Temperature controlled crimping
US7772359B2 (en) 2003-12-19 2010-08-10 Advanced Cardiovascular Systems, Inc. Biobeneficial polyamide/polyethylene glycol polymers for use with drug eluting stents
US7786249B2 (en) 2003-12-19 2010-08-31 Advanced Cardiovascular Systems, Inc. Biobeneficial polyamide/polyethylene glycol polymers for use with drug eluting stents
US8685431B2 (en) 2004-03-16 2014-04-01 Advanced Cardiovascular Systems, Inc. Biologically absorbable coatings for implantable devices based on copolymers having ester bonds and methods for fabricating the same
US8778014B1 (en) 2004-03-31 2014-07-15 Advanced Cardiovascular Systems, Inc. Coatings for preventing balloon damage to polymer coated stents
US7820732B2 (en) 2004-04-30 2010-10-26 Advanced Cardiovascular Systems, Inc. Methods for modulating thermal and mechanical properties of coatings on implantable devices
US9101697B2 (en) 2004-04-30 2015-08-11 Abbott Cardiovascular Systems Inc. Hyaluronic acid based copolymers
US8293890B2 (en) 2004-04-30 2012-10-23 Advanced Cardiovascular Systems, Inc. Hyaluronic acid based copolymers
US9561309B2 (en) 2004-05-27 2017-02-07 Advanced Cardiovascular Systems, Inc. Antifouling heparin coatings
US9375445B2 (en) 2004-06-18 2016-06-28 Abbott Cardiovascular Systems Inc. Heparin prodrugs and drug delivery stents formed therefrom
US8017140B2 (en) 2004-06-29 2011-09-13 Advanced Cardiovascular System, Inc. Drug-delivery stent formulations for restenosis and vulnerable plaque
US7758881B2 (en) 2004-06-30 2010-07-20 Advanced Cardiovascular Systems, Inc. Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders with an implantable medical device
US8758801B2 (en) 2004-07-30 2014-06-24 Abbott Cardiocascular Systems Inc. Coatings for implantable devices comprising poly(hydroxy-alkanoates) and diacid linkages
US8357391B2 (en) 2004-07-30 2013-01-22 Advanced Cardiovascular Systems, Inc. Coatings for implantable devices comprising poly (hydroxy-alkanoates) and diacid linkages
US9580558B2 (en) 2004-07-30 2017-02-28 Abbott Cardiovascular Systems Inc. Polymers containing siloxane monomers
US8586075B2 (en) 2004-07-30 2013-11-19 Abbott Cardiovascular Systems Inc. Coatings for implantable devices comprising poly(hydroxy-alkanoates) and diacid linkages
US7648727B2 (en) 2004-08-26 2010-01-19 Advanced Cardiovascular Systems, Inc. Methods for manufacturing a coated stent-balloon assembly
US7766884B2 (en) 2004-08-31 2010-08-03 Advanced Cardiovascular Systems, Inc. Polymers of fluorinated monomers and hydrophilic monomers
US8110211B2 (en) 2004-09-22 2012-02-07 Advanced Cardiovascular Systems, Inc. Medicated coatings for implantable medical devices including polyacrylates
US9067000B2 (en) 2004-10-27 2015-06-30 Abbott Cardiovascular Systems Inc. End-capped poly(ester amide) copolymers
US8603634B2 (en) 2004-10-27 2013-12-10 Abbott Cardiovascular Systems Inc. End-capped poly(ester amide) copolymers
US7749263B2 (en) 2004-10-29 2010-07-06 Abbott Cardiovascular Systems Inc. Poly(ester amide) filler blends for modulation of coating properties
US8609123B2 (en) 2004-11-29 2013-12-17 Advanced Cardiovascular Systems, Inc. Derivatized poly(ester amide) as a biobeneficial coating
US7892592B1 (en) 2004-11-30 2011-02-22 Advanced Cardiovascular Systems, Inc. Coating abluminal surfaces of stents and other implantable medical devices
US9339592B2 (en) 2004-12-22 2016-05-17 Abbott Cardiovascular Systems Inc. Polymers of fluorinated monomers and hydrocarbon monomers
US7699889B2 (en) 2004-12-27 2010-04-20 Advanced Cardiovascular Systems, Inc. Poly(ester amide) block copolymers
US8007775B2 (en) 2004-12-30 2011-08-30 Advanced Cardiovascular Systems, Inc. Polymers containing poly(hydroxyalkanoates) and agents for use with medical articles and methods of fabricating the same
US7795467B1 (en) 2005-04-26 2010-09-14 Advanced Cardiovascular Systems, Inc. Bioabsorbable, biobeneficial polyurethanes for use in medical devices
US8778375B2 (en) 2005-04-29 2014-07-15 Advanced Cardiovascular Systems, Inc. Amorphous poly(D,L-lactide) coating
US7823533B2 (en) 2005-06-30 2010-11-02 Advanced Cardiovascular Systems, Inc. Stent fixture and method for reducing coating defects
US8021676B2 (en) 2005-07-08 2011-09-20 Advanced Cardiovascular Systems, Inc. Functionalized chemically inert polymers for coatings
US7785647B2 (en) 2005-07-25 2010-08-31 Advanced Cardiovascular Systems, Inc. Methods of providing antioxidants to a drug containing product
US7735449B1 (en) 2005-07-28 2010-06-15 Advanced Cardiovascular Systems, Inc. Stent fixture having rounded support structures and method for use thereof
US8652504B2 (en) 2005-09-22 2014-02-18 Medivas, Llc Solid polymer delivery compositions and methods for use thereof
US9102830B2 (en) 2005-09-22 2015-08-11 Medivas, Llc Bis-(α-amino)-diol-diester-containing poly (ester amide) and poly (ester urethane) compositions and methods of use
US7976891B1 (en) 2005-12-16 2011-07-12 Advanced Cardiovascular Systems, Inc. Abluminal stent coating apparatus and method of using focused acoustic energy
US7867547B2 (en) 2005-12-19 2011-01-11 Advanced Cardiovascular Systems, Inc. Selectively coating luminal surfaces of stents
US8067025B2 (en) 2006-02-17 2011-11-29 Advanced Cardiovascular Systems, Inc. Nitric oxide generating medical devices
US7713637B2 (en) 2006-03-03 2010-05-11 Advanced Cardiovascular Systems, Inc. Coating containing PEGylated hyaluronic acid and a PEGylated non-hyaluronic acid polymer
US8596215B2 (en) 2006-05-04 2013-12-03 Advanced Cardiovascular Systems, Inc. Rotatable support elements for stents
US7985441B1 (en) 2006-05-04 2011-07-26 Yiwen Tang Purification of polymers for coating applications
US8003156B2 (en) 2006-05-04 2011-08-23 Advanced Cardiovascular Systems, Inc. Rotatable support elements for stents
US8741379B2 (en) 2006-05-04 2014-06-03 Advanced Cardiovascular Systems, Inc. Rotatable support elements for stents
US8069814B2 (en) 2006-05-04 2011-12-06 Advanced Cardiovascular Systems, Inc. Stent support devices
US8304012B2 (en) 2006-05-04 2012-11-06 Advanced Cardiovascular Systems, Inc. Method for drying a stent
US8465789B2 (en) 2006-05-04 2013-06-18 Advanced Cardiovascular Systems, Inc. Rotatable support elements for stents
US8637110B2 (en) 2006-05-04 2014-01-28 Advanced Cardiovascular Systems, Inc. Rotatable support elements for stents
US7775178B2 (en) 2006-05-26 2010-08-17 Advanced Cardiovascular Systems, Inc. Stent coating apparatus and method
US8568764B2 (en) 2006-05-31 2013-10-29 Advanced Cardiovascular Systems, Inc. Methods of forming coating layers for medical devices utilizing flash vaporization
US9561351B2 (en) 2006-05-31 2017-02-07 Advanced Cardiovascular Systems, Inc. Drug delivery spiral coil construct
US8703167B2 (en) 2006-06-05 2014-04-22 Advanced Cardiovascular Systems, Inc. Coatings for implantable medical devices for controlled release of a hydrophilic drug and a hydrophobic drug
US8778376B2 (en) 2006-06-09 2014-07-15 Advanced Cardiovascular Systems, Inc. Copolymer comprising elastin pentapeptide block and hydrophilic block, and medical device and method of treating
US8029816B2 (en) 2006-06-09 2011-10-04 Abbott Cardiovascular Systems Inc. Medical device coated with a coating containing elastin pentapeptide VGVPG
US8062350B2 (en) 2006-06-14 2011-11-22 Abbott Cardiovascular Systems Inc. RGD peptide attached to bioabsorbable stents
US8808342B2 (en) 2006-06-14 2014-08-19 Abbott Cardiovascular Systems Inc. Nanoshell therapy
US8603530B2 (en) 2006-06-14 2013-12-10 Abbott Cardiovascular Systems Inc. Nanoshell therapy
US8118863B2 (en) 2006-06-14 2012-02-21 Abbott Cardiovascular Systems Inc. RGD peptide attached to bioabsorbable stents
US8114150B2 (en) 2006-06-14 2012-02-14 Advanced Cardiovascular Systems, Inc. RGD peptide attached to bioabsorbable stents
US8048448B2 (en) 2006-06-15 2011-11-01 Abbott Cardiovascular Systems Inc. Nanoshells for drug delivery
US8017237B2 (en) 2006-06-23 2011-09-13 Abbott Cardiovascular Systems, Inc. Nanoshells on polymers
US8592036B2 (en) 2006-06-23 2013-11-26 Abbott Cardiovascular Systems Inc. Nanoshells on polymers
US8293367B2 (en) 2006-06-23 2012-10-23 Advanced Cardiovascular Systems, Inc. Nanoshells on polymers
US9028859B2 (en) 2006-07-07 2015-05-12 Advanced Cardiovascular Systems, Inc. Phase-separated block copolymer coatings for implantable medical devices
US8703169B1 (en) 2006-08-15 2014-04-22 Abbott Cardiovascular Systems Inc. Implantable device having a coating comprising carrageenan and a biostable polymer
US8597673B2 (en) 2006-12-13 2013-12-03 Advanced Cardiovascular Systems, Inc. Coating of fast absorption or dissolution
US8147769B1 (en) 2007-05-16 2012-04-03 Abbott Cardiovascular Systems Inc. Stent and delivery system with reduced chemical degradation
US9056155B1 (en) 2007-05-29 2015-06-16 Abbott Cardiovascular Systems Inc. Coatings having an elastic primer layer
US8109904B1 (en) 2007-06-25 2012-02-07 Abbott Cardiovascular Systems Inc. Drug delivery medical devices
US8048441B2 (en) 2007-06-25 2011-11-01 Abbott Cardiovascular Systems, Inc. Nanobead releasing medical devices
US10076591B2 (en) 2010-03-31 2018-09-18 Abbott Cardiovascular Systems Inc. Absorbable coating for implantable device

Similar Documents

Publication Publication Date Title
SU1016314A1 (en) Process for producing polyester urethanes
KR101952941B1 (en) Polyester resin and preparation method of the same
KR101969004B1 (en) Polyester resin and preparation method of the same
US8063169B2 (en) Preparation of polyamide block copolymers
CA2449034A1 (en) Copolyesters and polymerization of macrocyclic oligoesters
EP1056795B1 (en) Compositions based on 2-methyl-1,3-propanediol and a phthalic acid
WO2000011063A1 (en) A polyester resin and a process for preparing the same
JP2003507545A5 (en)
US10227446B2 (en) Method of producing glycolic acid polymers
US4182842A (en) Poly(ester-amides)prepared from an aromatic dicarboxylic acid, ethylene glycol and a p-acylaminobenzoic acid
EP0375960B1 (en) Thermoplastic, liquid-crystalline, wholly aromatic polyimide ester and method of producing the same
US6602963B2 (en) Polyesters containing (meth)acrylate end groups
CA2423828A1 (en) Polyester resins based on terephthalic acid and 2-methyl-1,3-propanediol and processes for the preparation thereof
EP1585779B1 (en) Catalyst complex for catalysing esterification and trans-esterification reactions and process for esterification /trans-esterification using the same
WO1994021708A1 (en) Aliphatic polyester and process for producing the same
Kricheldorf et al. Thermoplastic elastomers 1. Poly (ether-ester-imide) s based on 1, 4-diaminobutane, trimellitic anhydride, 1, 4-dihydroxybutane and poly (tetramethylene oxide) diols
KR101514786B1 (en) Polyester resin including component from biomass and preparation method of the same
KR101551930B1 (en) Preparation method of polyester resin including component from biomass
US5298591A (en) Non-crystalline wholly aromatic polyesters
JPH0753695A (en) Production of polyester carbonate
US5070176A (en) Melt phase polyarylate process
JPH0931176A (en) Production of biodegradable aliphatic polyester
JPH06192374A (en) Production of biodegradable polyester
JP3046658B2 (en) Method for producing polyester containing urethane bond
JP2000026589A (en) Production of polyhydroxycarboxylic acid